Pharmaceutical Research Insight

The National Institute of Health arranged for a panel to determine whether or not there is anything a person can do to reduce their risk of developing Alzheimer’s Dementia.

In our Q210 Pharmaceutical Business Environment Ratings (BER) matrix for Asia Pacific, Cambodia’s immature pharmaceutical market is found in last position of the 16 markets surveyed within the region.

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) .etc.,